Return to Statistics Toolbox

Random Forest analysis for Study ST000661

(Analysis AN001008 )

Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:1 Month | Treatment:Ornish | Type:Clinical
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:1 Month | Treatment:Southbeach | Type:Clinical
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:6 Months | Treatment:Ornish | Type:Clinical
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:6 Months | Treatment:Southbeach | Type:Clinical
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:Baseline | Treatment:Ornish | Type:Clinical
Sample type:Plasma | Sample_Source:Plasma | Species:Homo sapiens | Study:CHOICE | Time_Point:Baseline | Treatment:Southbeach | Type:Clinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:0 Days | Treatment:Baseline | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:27 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:27 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:29 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:29 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:34 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:34 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:36 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Plasma | Sample_Source:Plasma | Species:Rattus | Study:CSU-143 | Time_Point:36 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Plasma | Sample_Source:POOLED | Species:Homo sapiens | Study:POOLED | Time_Point:POOLED | Treatment:POOLED | Type:POOLED
Sample type:Plasma | Sample_Source:POOLED | Species:Rattus | Study:POOLED | Time_Point:POOLED | Treatment:POOLED | Type:POOLED
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:0 Days | Treatment:Baseline | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:27 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:27 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:29 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:29 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:34 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:34 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:36 Days | Treatment:Gainer (ad lib) | Type:Preclinical
Sample type:Tissues | Sample_Source:Mammary gland | Species:Rattus | Study:CSU-143 | Time_Point:36 Days | Treatment:Loser (40% DER) | Type:Preclinical
Sample type:Tissues | Sample_Source:POOLED | Species:Rattus | Study:POOLED | Time_Point:POOLED | Treatment:POOLED | Type:POOLED

  logo